Open Access
Med Sci (Paris)
Volume 34, Number 8-9, Août–Septembre 2018
Les Cahiers de Myologie
Page(s) 660 - 661
Section Le Magazine
Published online 19 September 2018
  1. Tang WHW Kitai T Hazen SL Gut microbiota in cardiovascular health and disease. Circ Res 2017 ; 120 : 1183–1196. [PubMed] [Google Scholar]
  2. Schroeder BO Bäckhed F Signals from the gut microbiota to distant organs in physiology and disease. Nat Med 2016 ; 22 : 1079–1089. [CrossRef] [PubMed] [Google Scholar]
  3. Mellor AL Munn DH IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol 2004 ; 4 : 762–774. [CrossRef] [PubMed] [Google Scholar]
  4. Puccetti P Grohmann U IDO and regulatory T cells: a role for reverse signalling and non-canonical NF-kappaB activation. Nat Rev Immunol 2007 ; 7 : 817–823. [CrossRef] [PubMed] [Google Scholar]
  5. Metghalchi S Ponnuswamy P Simon T et al. Indoleamine 2,3-dioxygenase fine-tunes immune homeostasis in atherosclerosis and colitis through repression of interleukin-10 production. Cell Metab 2015 ; 22 : 460–471. [CrossRef] [PubMed] [Google Scholar]
  6. Laurans L Venteclef N Haddad Y et al. Genetic deficiency of indoleamine 2,3-dioxygenase promotes gut microbiota-mediated metabolic health. Nat Med 2018 ; 24 : 1113–1120.10.1038/s41591-018-0060-4 [CrossRef] [PubMed] [Google Scholar]
  7. Turnbaugh PJ Ley RE Mahowald MA et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006 ; 444 : 1027–1031. [CrossRef] [PubMed] [Google Scholar]
  8. Lamas B Richard ML Leducq V et al. CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands. Nat Med 2016 ; 22 : 598–605. [CrossRef] [PubMed] [Google Scholar]
  9. Zelante T Iannitti RG Cunha C et al. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity 2013 ; 39 : 372–385. [CrossRef] [PubMed] [Google Scholar]
  10. Lamas B Richard ML Sokob H Card9 et colyte : un pont entre dysbiose et immunité. Med Sci (Paris) 2016 ; 32 : 933–936. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  11. Wang X Ota N Manzanillo P et al. Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetes. Nature 2014 ; 514 : 237–241. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.